Moderna Reports Covid Vaccine Safe for Children 6 to 12
October 28, 2021
The pharmaceutical giant plans to submit its findings later this week to federal regulators
Breaking News
- LACMA Showcases ‘Imagining Black Diasporas: 21st-Century Art and Poetics’ Exhibit
- Sheenway School and Culture Center — Educating Youth to Lead the Future Over 50 Years
- Record-Breaking Hate Crimes Against Black Angelenos on the Rise
- Los Angeles Rams and LAPD Spread Holiday Cheer with Annual Sleigh Ride
- Heather Hutt Sworn-in as Councilwoman for L.A.’s 10th District
- Visit Baldwin Hills Crenshaw Plaza for Holiday Photos with Santa
- Homeless and Their Advocates Speak Out in New Film, ‘WE, the Vulnerable of LA’
- The Congressman Wore Sneakers: An Evening With Hakeem Jeffries
- Brotherhood Crusade Honors SEIU President April Verrett at 2024 Pioneer of African American Achievement Award Dinner
- No. 18 UCLA Men’s Basketball Defeats Prairie View A&M 111-75
- Athletes in $2.8 billion college lawsuit tell judge they want to create a players’ association
- Cal, UNLV Inspire La Tijera Students at Day of Play
- Student Athlete of the Week: Koa Seymour
U.S. Food and Drug Administration
FDA Update on COVID-19 VACCINE BOOSTER DOSE
October 20, 2021
Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations.
Black Educators Take on Hesitancy as Gov. Newsom Issues COVID Vaccination Mandate
October 7, 2021
As the COVID-19 pandemic lingers on with Black Californians still lagging behind on getting fully vaccinated, leaders in the state, including Gov. Newsom, are taking steps to push more people to get the shot. It is the most effective way, public health experts say, we will end the global public health crisis.
Moderna Vaccine Appears to Offer Strongest Protection Against COVID
September 23, 2021
CDC Says All Vaccines Offer Strong Resistance to the Virus According to a new report from the Centers for Disease Control and Prevention, two-dose regimens of the Moderna and Pfizer-BioNTech mRNA vaccines provided a high level of protection against COVID-19 hospitalizations in a real-world evaluation at 21 U.S. hospitals during the period between March 11 and August 15. Vaccine effectiveness against COVID-19 hospitalization for Moderna and Pfizer-BioNTech doses were 93 percent and 88 percent, respectively, whereas the single-dose Janssen vaccine had a lower effectiveness rate at 71 percent. Protection for the Pfizer-BioNTech vaccine declined four months after
Cal Safety Workgroup Endorses COVID Vaccine Ahead of National Rollout This Week
December 17, 2020
Once the vaccines arrive in California, they will be sent to hospitals and other facilities that can store them at around minus 94 degrees Fahrenheit.
Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic
April 2, 2020
Based on recently completed studies and epidemiologic data, the FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply. Therefore, the FDA is revising recommendations in several guidances regarding blood donor eligibility. These changes are being put forth for immediate implementation and are expected to remain in place after the COVID-19 pandemic ends, with any appropriate changes based on comments we receive and our experience implementing the guidances. At this time, the alternatives to certain donor eligibility requirements being provided generally will apply only for the duration of the declared pandemic.
FDA to more aggressively tackle disruptive drug shortages
July 19, 2018
Most shortages involve low-profit generic pills and injections